CLARIANE SE (CLARI.PA) Stock Fundamental Analysis
EPA:CLARI - Euronext Paris - Matif - FR0010386334 - Common Stock - Currency: EUR
Taking everything into account, CLARI scores 3 out of 10 in our fundamental rating. CLARI was compared to 24 industry peers in the Health Care Providers & Services industry. CLARI has a bad profitability rating. Also its financial health evaluation is rather negative. CLARI has a valuation in line with the averages, but on the other hand it scores bad on growth.
1. Profitability
1.1 Basic Checks
In the past year CLARI has reported negative net income.
In the past year CLARI had a positive cash flow from operations.
In multiple years CLARI reported negative net income over the last 5 years.
CLARI had a positive operating cash flow in each of the past 5 years.
1.2 Ratios
The Return On Assets of CLARI (-0.39%) is worse than 70.83% of its industry peers.
The Return On Equity of CLARI (-1.49%) is worse than 70.83% of its industry peers.
CLARI's Return On Invested Capital of 1.86% is on the low side compared to the rest of the industry. CLARI is outperformed by 62.50% of its industry peers.
The Average Return On Invested Capital over the past 3 years for CLARI is below the industry average of 5.69%.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| ROA | -0.39% | ||
| ROE | -1.49% | ||
| ROIC | 1.86% |
ROA(3y)-0.31%
ROA(5y)0%
ROE(3y)-1.27%
ROE(5y)0.01%
ROIC(3y)1.96%
ROIC(5y)2.04%
1.3 Margins
With a Operating Margin value of 5.44%, CLARI perfoms like the industry average, outperforming 54.17% of the companies in the same industry.
CLARI's Operating Margin has declined in the last couple of years.
CLARI's Gross Margin of 91.68% is amongst the best of the industry. CLARI outperforms 100.00% of its industry peers.
In the last couple of years the Gross Margin of CLARI has remained more or less at the same level.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| OM | 5.44% | ||
| PM (TTM) | N/A | ||
| GM | 91.68% |
OM growth 3Y-16.28%
OM growth 5Y-11.33%
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y-0.3%
GM growth 5Y-0.14%
2. Health
2.1 Basic Checks
The Return on Invested Capital (ROIC) is below the Cost of Capital (WACC), so CLARI is destroying value.
CLARI has more shares outstanding than it did 1 year ago.
Compared to 5 years ago, CLARI has more shares outstanding
Compared to 1 year ago, CLARI has an improved debt to assets ratio.
2.2 Solvency
CLARI has an Altman-Z score of 0.62. This is a bad value and indicates that CLARI is not financially healthy and even has some risk of bankruptcy.
The Altman-Z score of CLARI (0.62) is worse than 62.50% of its industry peers.
CLARI has a debt to FCF ratio of 13.44. This is a negative value and a sign of low solvency as CLARI would need 13.44 years to pay back of all of its debts.
Looking at the Debt to FCF ratio, with a value of 13.44, CLARI is doing worse than 62.50% of the companies in the same industry.
A Debt/Equity ratio of 1.78 is on the high side and indicates that CLARI has dependencies on debt financing.
CLARI has a Debt to Equity ratio of 1.78. This is comparable to the rest of the industry: CLARI outperforms 45.83% of its industry peers.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Debt/Equity | 1.78 | ||
| Debt/FCF | 13.44 | ||
| Altman-Z | 0.62 |
ROIC/WACC0.45
WACC4.13%
2.3 Liquidity
A Current Ratio of 0.56 indicates that CLARI may have some problems paying its short term obligations.
With a Current ratio value of 0.56, CLARI is not doing good in the industry: 79.17% of the companies in the same industry are doing better.
A Quick Ratio of 0.56 indicates that CLARI may have some problems paying its short term obligations.
CLARI has a Quick ratio of 0.56. This is in the lower half of the industry: CLARI underperforms 66.67% of its industry peers.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Current Ratio | 0.56 | ||
| Quick Ratio | 0.56 |
3. Growth
3.1 Past
The Earnings Per Share has grown by an impressive 22.18% over the past year.
The Revenue has been growing slightly by 5.73% in the past year.
Measured over the past years, CLARI shows a small growth in Revenue. The Revenue has been growing by 7.89% on average per year.
EPS 1Y (TTM)22.18%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%99.24%
Revenue 1Y (TTM)5.73%
Revenue growth 3Y8.48%
Revenue growth 5Y7.89%
Sales Q2Q%4.4%
3.2 Future
CLARI is expected to show a strong growth in Earnings Per Share. In the coming years, the EPS will grow by 64.62% yearly.
Based on estimates for the next years, CLARI will show a small growth in Revenue. The Revenue will grow by 5.11% on average per year.
EPS Next Y157.21%
EPS Next 2Y90.37%
EPS Next 3Y64.62%
EPS Next 5YN/A
Revenue Next Year4.6%
Revenue Next 2Y4.82%
Revenue Next 3Y5.11%
Revenue Next 5YN/A
3.3 Evolution
When comparing the Revenue growth rate of the last years to the growth rate of the upcoming years, we see that the growth is decreasing.
4. Valuation
4.1 Price/Earnings Ratio
The Price/Earnings Ratio is negative for CLARI. In the last year negative earnings were reported.
Based on the Price/Forward Earnings ratio of 26.58, the valuation of CLARI can be described as expensive.
Based on the Price/Forward Earnings ratio, CLARI is valued a bit more expensive than the industry average as 62.50% of the companies are valued more cheaply.
CLARI's Price/Forward Earnings ratio indicates a valuation a bit more expensive than the S&P500 average which is at 21.38.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PE | N/A | ||
| Fwd PE | 26.58 |
4.2 Price Multiples
Based on the Enterprise Value to EBITDA ratio, CLARI is valued a bit cheaper than 62.50% of the companies in the same industry.
Based on the Price/Free Cash Flow ratio, CLARI is valued cheaply inside the industry as 95.83% of the companies are valued more expensively.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| P/FCF | 2.24 | ||
| EV/EBITDA | 8.87 |
4.3 Compensation for Growth
CLARI's low PEG Ratio(NY), which compensates the Price/Earnings for growth, indicates a rather cheap valuation of the company.
A more expensive valuation may be justified as CLARI's earnings are expected to grow with 64.62% in the coming years.
PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2Y90.37%
EPS Next 3Y64.62%
5. Dividend
5.1 Amount
CLARI has a Yearly Dividend Yield of 10.64%, which is a nice return.
Compared to an average industry Dividend Yield of 2.71, CLARI pays a better dividend. On top of this CLARI pays more dividend than 100.00% of the companies listed in the same industry.
CLARI's Dividend Yield is rather good when compared to the S&P500 average which is at 2.46.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Dividend Yield | 10.64% |
5.2 History
The dividend of CLARI decreases each year by -5.96%.
Dividend Growth(5Y)-5.96%
Div Incr Years0
Div Non Decr Years0
5.3 Sustainability
The earnings of CLARI are negative and hence is the payout ratio. CLARI will probably not be able to sustain this dividend level.
DP-92.12%
EPS Next 2Y90.37%
EPS Next 3Y64.62%
EPA:CLARI (4/30/2025, 4:56:25 PM)
3.724
-0.09 (-2.41%)
Chartmill FA Rating
GICS SectorHealth Care
GICS IndustryGroupHealth Care Equipment & Services
GICS IndustryHealth Care Providers & Services
Earnings (Last)
Earnings (Next)
Inst Owners41.38%
Inst Owner ChangeN/A
Ins Owners5.63%
Ins Owner ChangeN/A
Market Cap1.33B
Analysts45.45
Price Target2.79 (-25.08%)
Short Float %N/A
Short RatioN/A
Dividend
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Dividend Yield | 10.64% |
Yearly Dividend0.21
Dividend Growth(5Y)-5.96%
DP-92.12%
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)N/A
Avg EPS beat(2)N/A
Min EPS beat(2)N/A
Max EPS beat(2)N/A
EPS beat(4)N/A
Avg EPS beat(4)N/A
Min EPS beat(4)N/A
Max EPS beat(4)N/A
EPS beat(8)N/A
Avg EPS beat(8)N/A
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)N/A
Avg Revenue beat(2)N/A
Min Revenue beat(2)N/A
Max Revenue beat(2)N/A
Revenue beat(4)N/A
Avg Revenue beat(4)N/A
Min Revenue beat(4)N/A
Max Revenue beat(4)N/A
Revenue beat(8)N/A
Avg Revenue beat(8)N/A
Revenue beat(12)N/A
Avg Revenue beat(12)N/A
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)52.9%
PT rev (3m)52.9%
EPS NQ rev (1m)N/A
EPS NQ rev (3m)N/A
EPS NY rev (1m)2.64%
EPS NY rev (3m)440%
Revenue NQ rev (1m)N/A
Revenue NQ rev (3m)N/A
Revenue NY rev (1m)-0.45%
Revenue NY rev (3m)0.23%
Valuation
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PE | N/A | ||
| Fwd PE | 26.58 | ||
| P/S | 0.25 | ||
| P/FCF | 2.24 | ||
| P/OCF | 1.47 | ||
| P/B | 0.36 | ||
| P/tB | N/A | ||
| EV/EBITDA | 8.87 |
EPS(TTM)-0.47
EYN/A
EPS(NY)0.14
Fwd EY3.76%
FCF(TTM)1.66
FCFY44.65%
OCF(TTM)2.53
OCFY67.89%
SpS14.84
BVpS10.37
TBVpS-5.29
PEG (NY)N/A
PEG (5Y)N/A
Profitability
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| ROA | -0.39% | ||
| ROE | -1.49% | ||
| ROCE | 2.53% | ||
| ROIC | 1.86% | ||
| ROICexc | 1.95% | ||
| ROICexgc | 4.01% | ||
| OM | 5.44% | ||
| PM (TTM) | N/A | ||
| GM | 91.68% | ||
| FCFM | 11.21% |
ROA(3y)-0.31%
ROA(5y)0%
ROE(3y)-1.27%
ROE(5y)0.01%
ROIC(3y)1.96%
ROIC(5y)2.04%
ROICexc(3y)2.07%
ROICexc(5y)2.22%
ROICexgc(3y)4.16%
ROICexgc(5y)4.53%
ROCE(3y)2.66%
ROCE(5y)2.78%
ROICexcg growth 3Y-9.02%
ROICexcg growth 5Y-8.45%
ROICexc growth 3Y-9.61%
ROICexc growth 5Y-8.51%
OM growth 3Y-16.28%
OM growth 5Y-11.33%
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y-0.3%
GM growth 5Y-0.14%
F-Score5
Asset Turnover0.37
Health
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Debt/Equity | 1.78 | ||
| Debt/FCF | 13.44 | ||
| Debt/EBITDA | 6.65 | ||
| Cap/Depr | 43.77% | ||
| Cap/Sales | 5.83% | ||
| Interest Coverage | 0.96 | ||
| Cash Conversion | 90.82% | ||
| Profit Quality | N/A | ||
| Current Ratio | 0.56 | ||
| Quick Ratio | 0.56 | ||
| Altman-Z | 0.62 |
F-Score5
WACC4.13%
ROIC/WACC0.45
Cap/Depr(3y)69.7%
Cap/Depr(5y)78.91%
Cap/Sales(3y)9.85%
Cap/Sales(5y)11.22%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)22.18%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%99.24%
EPS Next Y157.21%
EPS Next 2Y90.37%
EPS Next 3Y64.62%
EPS Next 5YN/A
Revenue 1Y (TTM)5.73%
Revenue growth 3Y8.48%
Revenue growth 5Y7.89%
Sales Q2Q%4.4%
Revenue Next Year4.6%
Revenue Next 2Y4.82%
Revenue Next 3Y5.11%
Revenue Next 5YN/A
EBIT growth 1Y-8.92%
EBIT growth 3Y-9.18%
EBIT growth 5Y-4.33%
EBIT Next Year311.97%
EBIT Next 3Y70.36%
EBIT Next 5YN/A
FCF growth 1Y85%
FCF growth 3Y23.92%
FCF growth 5Y6.15%
OCF growth 1Y11.93%
OCF growth 3Y2.33%
OCF growth 5Y3.29%